Clicky

GenSight Biologics S.A(G49N) News

G49N price today by TradingView
Date Title
Feb 12 GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
Feb 12 GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study